2026 NPPES data Pediatric Neurodevelopmental Disabilities Physician NPI 1467488528 M.D.
Verify on CMS →

Christopher Giza, M.D.

Pediatric Neurodevelopmental Disabilities Physician in Los Angeles, California.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 286 in Pediatric Neurodevelopmental Disabilities Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
44
Medicare Part D claims · Pediatric Neurodevelopmental Disabilities Physician avg: 386
MIPS score
80.5/100
▼ 3 pts below national avg 83.1 · Above neutral
Industry payments
$166.77
3 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Christopher Giza, M.D. reported a CMS MIPS final score of 80.5/100 - below the 83.1 national average - and filed 44 Medicare Part D claims in 2023.

80.5/100
MIPS score · -3 vs avg
44
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Christopher Giza, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

81 33rd percentile higher than 33% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Christopher Giza, M.D. sits

This provider among pediatric neurodevelopmental disabilities physician peers

Across the 17 pediatric neurodevelopmental disabilities physician providers who report both Medicare Part D prescribing and a MIPS quality score, Christopher Giza, M.D. writes more Part D claims than 24% of them and scores higher on MIPS quality than 29% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.749.474.098.7Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 94Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 31Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 50Part D claim volume, percentile in specialty: 19 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 81 · MIPS quality, percentile: 94Part D claim volume, percentile in specialty: 69 · MIPS quality, percentile: 31Part D claim volume, percentile in specialty: 44 · MIPS quality, percentile: 25Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 94 · MIPS quality, percentile: 81Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 6Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 6Part D claim volume, percentile in specialty: 56 · MIPS quality, percentile: 56Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 6 · MIPS quality, percentile: 69Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 19Christopher Giza, M.D.-Part D claim volume, percentile in specialty: 24 · MIPS quality, percentile: 29
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one pediatric neurodevelopmental disabilities physician peer from a representative sample of 16; the gold marker is Christopher Giza, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Christopher Giza, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Christopher Giza, M.D.?

Near national average

NPI registry status

Active

Issued 06/23/2006

NPI 1467488528

Primary specialty

Pediatric Neurodevelopmental Disabilities Physician

Rare

286 US NPIs in this specialty

Medicare Part D claims

44 89% vs specialty avg

2023 prescription claims

Specialty avg: 386

MIPS final score

80.5/100 2.6 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Pediatric Neurodevelopmental Disabilities Physician compares to other specialties among California providers

California providers
Behavior Technician - 17.3%Behavior Technician17.3%Marriage & Family Therapist - 5.5%Marriage & Family Therapist5.5%Student in an Organized Health Care Education/Training Program - 5%Student in an Organized Health Care Education/Training Program5%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Pharmacist - 3.5%Pharmacist3.5%Clinical Social Worker - 3.1%Clinical Social Worker3.1%Pediatric Neurodevelopmental Disabilities Physician - 0%Pediatric Neurodevelopmental Disabilities Physician0%
Largest specialties in California (% of in-state providers)

Medicare quality performance, MIPS

Christopher Giza, M.D.'s 2023 MIPS final score plotted against the Pediatric Neurodevelopmental Disabilities Physician national average

Near national average
MIPS Final Score
80.5/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pediatric Neurodevelopmental Disabilities Physician) - 80.5/100 vs national avg 83.1

0%100%National avg83%80.5%
MIPS final score (Pediatric Neurodevelopmental Disabilities Physician) - 80.5/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Christopher Giza, M.D. appears in the CMS NPPES registry as a Pediatric Neurodevelopmental Disabilities Physician provider holding M.D. credentials at 10833 LE CONTE AVE, Los Angeles, CA, 90095, with a listed phone of (310) 825-6196. NPI 1467488528 was issued on 06/23/2006.

Medicare Part D records for calendar year 2023 show 44 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $3K in drug spend. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 80.5/100 for the 2023 performance year (Quality 80.8, Cost 20.9), compared with the national average of 83.1.

Pediatric Neurodevelopmental Disabilities Physician is a narrow specialty nationwide, with 286 enrolled providers across 41 states and an average of 386 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10833 LE CONTE AVE
Los Angeles, CA 90095

Provider Details

NPI 1467488528
Specialty Pediatric Neurodevelopmental Disabilities Physician
Credentials M.D.
Gender Male
NPI Issued 06/23/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

80.5085
Final Score
Avg: 83.1
80.838
Quality
20.857
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Christopher Giza, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UC Regents
Los Angeles, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Christopher Giza, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$167

Largest payer

JAZZ PHARMACEUTICALS INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Christopher Giza, M.D.. To verify Christopher Giza, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

44
Total Claims
$3K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
54
Total Day Supply
1,530
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
37.2 years
Avg HCC Risk Score
0.99

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tizanidine Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Neurodevelopmental Disabilities Physician Overview

How Christopher Giza, M.D. fits within the Pediatric Neurodevelopmental Disabilities Physician landscape nationally.

286
Pediatric Neurodevelopmental Disabilities Physician Providers in US
41
States with Pediatric Neurodevelopmental Disabilities Physician
386
Avg Claims per Provider

Christopher Giza, M.D.'s 44 claims are below the specialty average of 386.

Nearby Pediatric Neurodevelopmental Disabilities Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Giza.

Compare Pediatric Neurodevelopmental Disabilities Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pediatric Neurodevelopmental Disabilities Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Christopher Giza, M.D.'s specialty?
Christopher Giza, M.D. specializes in Pediatric Neurodevelopmental Disabilities Physician and practices in Los Angeles, California. Credentials: M.D..
How much does Christopher Giza, M.D. prescribe under Medicare Part D?
In 2023, Christopher Giza, M.D. wrote 44 Medicare Part D claims totaling $3K in drug costs for N/A beneficiaries.
What is Christopher Giza, M.D.'s Medicare quality score?
Christopher Giza, M.D. has a CMS MIPS Final Score of 80.5/100 (Quality: 80.8, Cost: 20.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Christopher Giza, M.D. located?
Christopher Giza, M.D. is located at 10833 LE CONTE AVE, Los Angeles, CA, 90095. Phone: (310) 825-6196.
What is Christopher Giza, M.D.'s NPI number?
Christopher Giza, M.D.'s National Provider Identifier (NPI) is 1467488528, issued on 06/23/2006.
How many Pediatric Neurodevelopmental Disabilities Physician providers are there in the US?
There are 286 Pediatric Neurodevelopmental Disabilities Physician providers across 41 states in the US. The average Pediatric Neurodevelopmental Disabilities Physician provider writes 386 Medicare Part D claims per year.
What drugs does Christopher Giza, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Christopher Giza, M.D.'s most frequently prescribed drugs include Tizanidine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Christopher Giza, M.D. accept Medicare?
Christopher Giza, M.D. appears in CMS Medicare data with 44 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Christopher Giza, M.D.'s credentials?
Christopher Giza, M.D.'s NPI is 1467488528 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.